ResMed(RMD) - 2024 Q2 - Earnings Call Transcript

ResMed Inc. (NYSE:RMD) Q2 2024 Earnings Conference Call January 24, 2024 4:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Michael Farrell - Chief Executive Officer Brett Sandercock - Chief Financial Officer Conference Call Participants Margaret Andrew - William Blair & Co. LLC Anthony Petrone - Mizuho Securities USA LLC Michael Matson - Needham & Company, LLC Suraj Kalia - Oppenheimer & Co. Inc. Steven Wheen - Jarden Saul Hadassin - Barrenjoey Capital Mathieu ...